Trump Impact on Medicare Drug Price Negotiations Uncertain
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and experimental pricing models for gene therapies. But so far the healthcare elements of the Inflation Reduction Act remain unchanged.
Trump Order Walks Back Biden-Era Effort To Lower Prescription Drug Prices. Here's Context
Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid agencies to research and implement models for lowering the costs of prescription drugs. Separate provisions in the Inflation Reduction Act of 2022 also aimed at lower prescription drug costs are still in effect.
Among the myriad executive orders signed by President Donald Trump on Inauguration Day Monday was one that freezes new ...
The Donald Trump administration has ordered a halt to all diversity, equity and inclusion (DEI) initiatives, placing staff on ...
President Donald Trump made good on his campaign promises to kick off his second term in office with a tidal wave of ...
Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.
Elon Musk has expressed doubts about the financial feasibility of the $500 billion Stargate AI Project announced by President ...
Explore the remarkable 20-year love story of Donald and Melania Trump, from their first meeting at a New York City party to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback